Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exubera versus Humalog, both with insulin glargine, in type 1 diabetes
2004-001557-29Phase 4Terminated
- Sponsor
- Pfizer
- Start
- Oct 2006
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Technosphere insulin in diabetes mellitus type 1 (T1D) (2 arms), sponsored by Pfizer. Primary endpoint: Change in HbA1c from baseline to week 52. Started Oct 2006; status: terminated.
02
Drugs
Technosphere insulin
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2004-001557-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001557-29.